Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The TEL-AML1 leukemia fusion gene dysregulates the TGF-β pathway in early B lineage progenitor cells
Anthony M. Ford, … , Tariq Enver, Mel Greaves
Anthony M. Ford, … , Tariq Enver, Mel Greaves
Published March 16, 2009
Citation Information: J Clin Invest. 2009;119(4):826-836. https://doi.org/10.1172/JCI36428.
View: Text | PDF
Research Article Oncology Article has an altmetric score of 1

The TEL-AML1 leukemia fusion gene dysregulates the TGF-β pathway in early B lineage progenitor cells

  • Text
  • PDF
Abstract

Chromosome translocation to generate the TEL-AML1 (also known as ETV6-RUNX1) chimeric fusion gene is a frequent and early or initiating event in childhood acute lymphoblastic leukemia (ALL). Our starting hypothesis was that the TEL-AML1 protein generates and maintains preleukemic clones and that conversion to overt disease requires secondary genetic changes, possibly in the context of abnormal immune responses. Here, we show that a murine B cell progenitor cell line expressing inducible TEL-AML1 proliferates at a slower rate than parent cells but is more resistant to further inhibition of proliferation by TGF-β. This facilitates the competitive expansion of TEL-AML1–expressing cells in the presence of TGF-β. Further analysis indicated that TEL-AML1 binds to a principal TGF-β signaling target, Smad3, and compromises its ability to activate target promoters. In mice expressing a TEL-AML1 transgene, early, pre-pro-B cells were increased in number and also showed reduced sensitivity to TGF-β–mediated inhibition of proliferation. Moreover, expression of TEL-AML1 in human cord blood progenitor cells led to the expansion of a candidate preleukemic stem cell population that had an early B lineage phenotype (CD34+CD38–CD19+) and a marked growth advantage in the presence of TGF-β. Collectively, these data suggest a plausible mechanism by which dysregulated immune responses to infection might promote the malignant evolution of TEL-AML1–expressing preleukemic clones.

Authors

Anthony M. Ford, Chiara Palmi, Clara Bueno, Dengli Hong, Penny Cardus, Deborah Knight, Giovanni Cazzaniga, Tariq Enver, Mel Greaves

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Total
Citations: 2 4 7 3 6 3 3 3 3 1 9 5 3 1 4 4 2 63
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (63)

Title and authors Publication Year
H1‐0 is a specific mediator of the repressive ETV6::RUNX1 transcriptional landscape in preleukemia and B cell acute lymphoblastic leukemia
Jepsen VH, Hanel A, Picard D, Bhave R, Hasselmann R, Mehtonen J, Schliehe\u2010Diecks J, Kath C, Suppiyar V, Prasad Y, Schaal K, Tu J, Rüchel N, Kameri E, Qin N, Wang H, Zhuang Z, Wagener R, Blümel L, Lautwein T, Hein D, Koppstein D, Kögler G, Remke M, Bhatia S, Heinäniemi M, Borkhardt A, Fischer U
HemaSphere 2025
Comparative Profiling of Regulatory Modules as a Tool for Identifying the Transcription Factor Network Linked to Leukemogenesis.
Subramanian S, Phongbunchoo Y, Cauchy P, Ramamoorthy S
Methods in molecular biology (Clifton, N.J.) 2025
Inflammation as a driver of hematological malignancies
Saluja S, Bansal I, Bhardwaj R, Beg MS, Palanichamy JK
Frontiers in Oncology 2024
The Diverse Roles of ETV6 Alterations in B-Lymphoblastic Leukemia and Other Hematopoietic Cancers.
Monovich AC, Gurumurthy A, Ryan RJH
Advances in experimental medicine and biology 2024
Identification of Gene Regulatory Networks in B-Cell Progenitor Differentiation and Leukemia
Nagel S, Meyer C
Genes 2024
Impact of genetic alterations on central nervous system progression of primary vitreoretinal lymphoma
Yoshifuji K, Sadato D, Toya T, Motomura Y, Hirama C, Takase H, Yamamoto K, Harada Y, Mori T, Nagao T
Haematologica 2024
Cytokine Hyperresponsiveness in Children With ETV6::RUNX1-positive Acute Lymphoblastic Leukemia After Challenge With Common Pathogens
Rüchel N, Oldenburg M, Janssen S, Pandyra AA, Liu W, Vasileiou E, Hein D, Jepsen VH, Fischer U, Picard D, Kögler G, Hauer J, Auer F, Beer A, Adams O, MacKenzie C, Jaeger M, Netea MG, Borkhardt A, Gössling KL
HemaSphere 2023
The role of microenvironment in the initiation and evolution of B-cell precursor acute lymphoblastic leukemia
Garcia-Gimenez A, Richardson SE
Frontiers in Oncology 2023
Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice.
Isidro-Hernández M, Casado-García A, Oak N, Alemán-Arteaga S, Ruiz-Corzo B, Martínez-Cano J, Mayado A, Sánchez EG, Blanco O, Gaspar ML, Orfao A, Alonso-López D, De Las Rivas J, Riesco S, Prieto-Matos P, González-Murillo Á, Criado FJG, Cenador MBG, Ramírez-Orellana M, de Andrés B, Vicente-Dueñas C, Cobaleda C, Nichols KE, Sánchez-García I
Nature Communications 2023
Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR(+) Acute Lymphoblastic Leukemia.
Mostufi-Zadeh-Haghighi G, Veratti P, Zodel K, Greve G, Waterhouse M, Zeiser R, Cleary ML, Lübbert M, Duque-Afonso J
Cancers 2023
Lessons from mouse models in the impact of risk factors on the genesis of childhood B-cell leukemia
Casado-García A, Isidro-Hernández M, Alemán-Arteaga S, Ruiz-Corzo B, Riesco S, Prieto-Matos P, Sánchez L, Sánchez-García I, Vicente-Dueñas C
Frontiers in immunology 2023
Age and ligand specificity influence the outcome of pathogen engagement on preleukemic and leukemic B-cell precursor populations
Atre T, Farrokhi A, Jo S, Salitra S, Duque-Afonso J, Cleary ML, Rolf N, Reid GS
Blood Advances 2023
SPAG6 regulates cell proliferation and apoptosis via TGF-β/Smad signal pathway in adult B-cell acute lymphoblastic leukemia.
Zhao B, Yin J, Ding L, Luo J, Luo J, Mu J, Pan S, Du J, Zhong Y, Zhang L, Liu L
International Journal of Hematology 2023
Childhood B-Cell Preleukemia Mouse Modeling
Isidro-Hernández M, Alemán-Arteaga S, Casado-García A, Ruiz-Corzo B, Riesco S, Prieto-Matos P, Martínez-Cano J, Sánchez L, Cobaleda C, Sánchez-García I, Vicente-Dueñas C
International journal of molecular sciences 2022
Mesenchymal Stromal Cells (MSCs): An Ally of B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells in Disease Maintenance and Progression within the Bone Marrow Hematopoietic Niche
Fallati A, Di Marzo N, D\u2019Amico G, Dander E
Cancers 2022
Regulome analysis in B-acute lymphoblastic leukemia exposes Core Binding Factor addiction as a therapeutic vulnerability
Wray JP, Deltcheva EM, Boiers C, Richardson SЕ, Chhetri JB, Brown J, Gagrica S, Guo Y, Illendula A, Martens JH, Stunnenberg HG, Bushweller JH, Nimmo R, Enver T
Nature Communications 2022
Toward prevention of childhood ALL by early-life immune training
J Hauer, U Fischer, A Borkhardt
Blood 2021
The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia
E Dander, C Palmi, G DAmico, G Cazzaniga
International journal of molecular sciences 2021
Cancer microenvironment and genomics: evolution in process
SP Leong, IP Witz, O Sagi-Assif, S Izraely, J Sleeman, B Piening, BA Fox, CB Bifulco, R Martini, L Newman, M Davis, LM Sanders, D Haussler, OM Vaske, M Witte
Clinical & Experimental Metastasis 2021
The distinct effects of P18 overexpression on different stages of hematopoiesis involve TGF-β and NF-κB signaling
Yi D, Zhu L, Liu Y, Zeng J, Chang J, Sun W, Teng J, Zhang Y, Dong Y, Pan X, Chen Y, Zhou Y, Lai M, Zhou Q, Liu J, Chen B, Ma F
Scientific Reports 2021
Can we prevent childhood Leukaemia?
Greaves M, Cazzaniga V, Ford A
Leukemia 2021
Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia.
Iglesias P, Puller AC, Seoane M, Spohn M, Raasch S, Klokow M, Müller J, Burkhardt L, Indenbirken D, Horstmann MA
Blood Advances 2021
Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities
J Mehtonen, S Teppo, M Lahnalampi, A Kokko, R Kaukonen, L Oksa, M Bouvy-Liivrand, A Malyukova, A Mäkinen, S Laukkanen, PI Mäkinen, S Rounioja, P Ruusuvuori, O Sangfelt, R Lund, T Lönnberg, O Lohi, M Heinäniemi
Genome Medicine 2020
Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis.
Isidro-Hernández M, Mayado A, Casado-García A, Martínez-Cano J, Palmi C, Fazio G, Orfao A, Ribera J, Ribera JM, Zamora L, Raboso-Gallego J, Blanco O, Alonso-López D, De Las Rivas J, Jiménez R, García Criado FJ, García Cenador MB, Ramírez-Orellana M, Cazzaniga G, Cobaleda C, Vicente-Dueñas C, Sánchez-García I
Scientific Reports 2020
LeukmiR: a database for miRNAs and their targets in acute lymphoblastic leukemia.
Rawoof A, Swaminathan G, Tiwari S, Nair RA, Dinesh Kumar L
Database : the journal of biological databases and curation 2020
The Role of MicroRNA in Paediatric Acute Lymphoblastic Leukaemia: Challenges for Diagnosis and Therapy
C Grobbelaar, AM Ford
Journal of Oncology 2019
The role of TGFβ in hematopoiesis and myeloid disorders.
Bataller A, Montalban-Bravo G, Soltysiak KA, Garcia-Manero G
Leukemia 2019
Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia
Bloom M, Maciaszek JL, Clark ME, Pui CH, Nichols KE
Expert Review of Hematology 2019
A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to B Acute Lymphoblastic Leukemia-Associated ETV6-RUNX1
C Böiers, SE Richardson, E Laycock, A Zriwil, VA Turati, J Brown, JP Wray, D Wang, C James, J Herrero, E Sitnicka, S Karlsson, AJ Smith, SE Jacobsen, T Enver
Developmental Cell 2018
Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia
R Polak, MB Bierings, CS van der Leije, MA Sanders, O Roovers, JR Marchante, JM Boer, JJ Cornelissen, R Pieters, ML den Boer, M Buitenhuis
Haematologica 2018
A causal mechanism for childhood acute lymphoblastic leukaemia.
Greaves M
Nature reviews. Cancer 2018
Modeling the process of childhood ETV6-RUNX1 B-cell leukemias
G Rodríguez-Hernández, D Schäfer, A Gavilán, C Vicente-Dueñas, J Hauer, A Borkhardt, I Sánchez-García
Oncotarget 2017
Regulation of Hematopoiesis and Hematological Disease by TGF-β Family Signaling Molecules
K Naka, A Hirao
Cold Spring Harbor perspectives in biology 2017
Transforming growth factor-β1 regulates the nascent hematopoietic stem cell niche by promoting gluconeogenesis.
Zhang CY, Yin HM, Wang H, Su D, Xia Y, Yan LF, Fang B, Liu W, Wang YM, Gu AH, Zhou Y
Leukemia 2017
Inhibition of precursor B-cell malignancy progression by toll-like receptor ligand-induced immune responses
M Fidanza, AE Seif, A DeMicco, N Rolf, S Jo, B Yin, Y Li, DM Barrett, J Duque-Afonso, ML Cleary, CH Bassing, SA Grupp, GS Reid
Leukemia 2016
Stem cell programs are retained in human leukemic lymphoblasts
D Fan, X Zhou, Z Li, ZQ Li, C Duan, T Liu, F Zhang, Y Huang, Y Zhang, F Gao, Y Guo, R Gupta, G Chen, T Enver, J Tang, D Hong
Oncogene 2015
Mouse models for core binding factor leukemia
DW Chin, N Watanabe-Okochi, CQ Wang, V Tergaonkar, M Osato
Leukemia 2015
Childhood acute lymphoblastic leukaemia and indicators of early immune stimulation: the Estelle study (SFCE)
R Ajrouche, J Rudant, L Orsi, A Petit, A Baruchel, A Lambilliotte, M Gambart, G Michel, Y Bertrand, S Ducassou, V Gandemer, C Paillard, L Saumet, N Blin, D Hémon, J Clavel
British Journal of Cancer 2015
Bone Marrow Cells in Acute Lymphoblastic Leukemia Create a Proinflammatory Microenvironment Influencing Normal Hematopoietic Differentiation Fates
A Vilchis-Ordoñez, A Contreras-Quiroz, E Vadillo, E Dorantes-Acosta, A Reyes-López, HM Prado, J Venegas-Vázquez, H Mayani, V Ortiz-Navarrete, B López-Martínez, R Pelayo
BioMed Research International 2015
Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia
S Swaminathan, L Klemm, E Park, E Papaemmanuil, A Ford, SM Kweon, D Trageser, B Hasselfeld, N Henke, J Mooster, H Geng, K Schwarz, SC Kogan, R Casellas, DG Schatz, MR Lieber, MF Greaves, M Müschen
Nature Immunology 2015
Childhood Acute Lymphoblastic Leukemia and Indicators of Early Immune Stimulation: A Childhood Leukemia International Consortium Study
J Rudant, T Lightfoot, KY Urayama, E Petridou, JD Dockerty, C Magnani, E Milne, LG Spector, LJ Ashton, N Dessypris, AY Kang, M Miller, R Rondelli, J Simpson, E Stiakaki, L Orsi, E Roman, C Metayer, C Infante-Rivard, J Clavel
American Journal of Epidemiology 2015
Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing
Y Jin, X Wang, S Hu, J Tang, B Li, Y Chai
Cancer Medicine 2015
Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia
A Sanjuan-Pla, C Bueno, C Prieto, P Acha, RW Stam, R Marschalek, P Menendez
Blood 2015
Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse
C Sun, L Chang, X Zhu
Oncotarget 2015
Murine Models of Acute Leukemia: Important Tools in Current Pediatric Leukemia Research
E Jacoby, CD Chien, TJ Fry
Frontiers in Oncology 2014
Incidence of common preleukemic gene fusions in umbilical cord blood in Slovak population
M Škorvaga, E Nikitina, M Kubeš, P Košík, B Gajdošechová, M Leitnerová, L Copáková, I Belyaev
PloS one 2014
The prenatal origins of cancer
GM Marshall, DR Carter, BB Cheung, T Liu, MK Mateos, JG Meyerowitz, WA Weiss
Nature Reviews Cancer 2014
Genetically engineered mouse models of human B-cell precursor leukemias
J Hauer, A Borkhardt, I Sánchez-García, C Cobaleda
Cell cycle (Georgetown, Tex.) 2014
Identification of TEL-AML1 (ETV6-RUNX1) associated DNA and its impact on mRNA and protein output using ChIP, mRNA expression arrays and SILAC
Y Linka, S Ginzel, A Borkhardt, P Landgraf
Genomics Data 2014
The impact of TEL-AML1 (ETV6-RUNX1) expression in precursor B cells and implications for leukaemia using three different genome-wide screening methods
Y Linka, S Ginzel, M Krüger, A Novosel, M Gombert, E Kremmer, J Harbott, R Thiele, A Borkhardt, P Landgraf
Blood Cancer Journal 2013
Acute lymphoblastic leukaemia
H Inaba, M Greaves, CG Mullighan
Lancet 2013
Molecular mechanisms of ETS transcription factor-mediated tumorigenesis
A Kar, A Gutierrez-Hartmann
Critical Reviews in Biochemistry and Molecular Biology 2013
TGF-β - an excellent servant but a bad master
L Kubiczkova, L Sedlarikova, R Hajek, S Sevcikova
Journal of Translational Medicine 2012
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy
D Bhojwani, D Pei, JT Sandlund, S Jeha, RC Ribeiro, JE Rubnitz, SC Raimondi, S Shurtleff, M Onciu, C Cheng, E Coustan-Smith, WP Bowman, SC Howard, ML Metzger, H Inaba, W Leung, WE Evans, D Campana, MV Relling, CH Pui
Leukemia 2011
Stem cell niches and other factors that influence the sensitivity of bone marrow to radiation-induced bone cancer and leukaemia in children and adults
RB Richardson
International Journal of Radiation Biology 2011
The Leukemia-Specific Fusion Gene ETV6/RUNX1 Perturbs Distinct Key Biological Functions Primarily by Gene Repression
G Fuka, M Kauer, R Kofler, OA Haas, R Panzer-Grümayer
PloS one 2011
Research recommendations toward a better understanding of the causes of childhood leukemia
Ziegelberger G, Baum C, Borkhardt A, Cobaleda C, Dasenbrock C, Dehos A, Grosche B, Hauer J, Hornhardt S, Jung T, Kammertoens T, Lagroye I, Lehrach H, Lightfoot T, Little MP, Rossig C, Sanchez-Garcia I, Schrappe M, Schuez J, Shalapour S, Slany R, Stanulla M, Weiss W
Blood Cancer Journal 2011
Metastatic Bone Disease: Role of Transcription Factors and Future Targets
J Pratap, JB Lian, GS Stein
Bone 2010
TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a
C Diakos, S Zhong, Y Xiao, M Zhou, GM Vasconcelos, G Krapf, RF Yeh, S Zheng, M Kang, JK Wiencke, MS Pombo-de-Oliveira, R Panzer-Grümayer, JL Wiemels
Blood 2010
Germinal and Somatic Trisomy 21 Mosaicism: How Common is it, What are the Implications for Individual Carriers and How Does it Come About?
MA Hultén, J Jonasson, A Nordgren, E Iwarsson
Current genomics 2010
ETV6/RUNX1 abrogates mitotic checkpoint function and targets its key player MAD2L1
G Krapf, U Kaindl, A Kilbey, G Fuka, A Inthal, R Joas, G Mann, JC Neil, OA Haas, ER Panzer-Grümayer
Oncogene 2010
Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53
N Gefen, V Binder, M Zaliova, Y Linka, M Morrow, A Novosel, L Edry, L Hertzberg, N Shomron, O Williams, J Trka, A Borkhardt, S Izraeli
Leukemia 2009
The ‘delayed infection’ (aka ‘hygiene’) hypothesis for childhood leukaemia
Greaves M
2009

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Highlighted by 1 platforms
124 readers on Mendeley
1 readers on CiteULike
See more details